---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-292015"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2025-11-24T23:59:59+00:00"
generated_at: "2026-05-16T17:21:57.094878+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Centessa Pharma enters into $250M ATM equity offering facility with Leerink Partners

## Summary
- Up to $250M of American Depositary Shares may be sold through Leerink as sales agent.
- Commission of 3.0% on gross proceeds; Leerink also receives up to $150K legal expense reimbursement.
- No minimum offering amount; net proceeds expected for working capital, capex, and general corporate purposes.
- Amends and restates prior sales agreement dated January 27, 2023, with Leerink.

## SEC filing metadata
- accession: 0001193125-25-292015
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2025-11-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000119312525292015/0001193125-25-292015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000119312525292015/d23843d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-292015
- JSON: https://secwatch.observer/filing/0001193125-25-292015.json
- Plain text: https://secwatch.observer/filing/0001193125-25-292015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.